Available Technologies   //   Inventor Portal

Get Started with the Polsky Center

Featured

Small Business Spotlight: Qui Solutions Unlocks the Potential Behind BIPOC and Woman-owned Businesses

Read More
See All Podcasts
Small Business Spotlight: Qui Solutions Unlocks the Potential Behind BIPOC and Woman-owned Businesses
1 / 1
Small Business Spotlight: Qui Solutions Unlocks the Potential Behind BIPOC and Woman-owned Businesses

Alnair Therapeutics Follows Polsky Path to String of Impressive Wins, $1M+ Funding Round

Momentum continues to build for Alnair Therapeutics, an oncology startup focused on developing a platform to better deliver drugs to hard-to-treat cancers. In June – the same month that…

Oncology Startup Takes Home First Place at 2023 NVC as Judges Award $1.4M in Total Investment

  Alnair Therapeutics, a startup developing a platform technology to improve the delivery of drugs to difficult-to-treat cancers, has won first place in the 27th Annual Edward L. Kaplan, ’71,…

Ten Startups Will Compete for Over $1M in Finals of 27th Annual Edward L. Kaplan, ’71, New Venture Challenge

The Polsky Center for Entrepreneurship and Innovation is pleased to announce the 10 teams selected to advance to the finals of the 27th annual Edward L. Kaplan, ’71, New Venture…

25 Teams Advance to Phase II of the 2023 Edward L. Kaplan, ’71 New Venture Challenge

The Polsky Center for Entrepreneurship and Innovation is pleased to announce the 25 Phase II teams advancing in the 2023 Edward L. Kaplan, ’71, New Venture Challenge (NVC), the…

2 Startups Awarded $175,000 Each to Further Develop Cancer Treatment Technologies

Alnair Therapeutics and Riptide Therapeutics have been awarded investments from the George Shultz Innovation Fund to further develop their cancer treatment technologies. Both will receive $175,000 investments from the Fund.…

Riptide Therapeutics Awarded $175,000 From George Shultz Innovation Fund

The George Shultz Innovation Fund (GSIF), managed by the Polsky Center for Entrepreneurship and Innovation, recently selected Riptide Therapeutics, a biopharmaceutical startup led by University of Chicago and Northwestern University…

Alnair Therapeutics Awarded $175,000 From George Shultz Innovation Fund

The George Shultz Innovation Fund (GSIF), managed by the Polsky Center for Entrepreneurship and Innovation, recently selected oncology startup Alnair Therapeutics as a Fall 2022 cohort award winner. The company,…

Digital Health, Therapeutics Startups Selected for George Shultz Innovation Fund Finals

The Polsky Center for Entrepreneurship and Innovation at the University of Chicago has announced the companies selected for the 2022 fall cohort of the George Shultz Innovation Fund. Managed by…

50 Companies to Pitch to Investors at DeepTechU

The DeepTechU venture conference will showcase 50 startups during the three-day virtual event May 3 to 5, giving investors an early look at cutting-edge deep tech…

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept